Fund Holdings — Darwin Global Management, Ltd.

Total Portfolio Value
$3.60B
Total Bought
$1.64B
Total Sold
$420.78M
Net Transaction
+$1.21B
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
INSMED INC(INSM)19,344,62120,457,445+1,112,8241,924,5962,897,79780.54%+973,201
UNITED THERAPEUTICS CORP DEL(UTHR)0748,550+748,5500317,6178.83%+317,617
ABIVAX SA(ABVX)03,164,501+3,164,5010263,6987.33%+263,698
CIDARA THERAPEUTICS INC768,424997,196+228,77237,99994,9932.64%+56,994
UNIQURE NV(QURE)0400,000+400,000023,7600.66%+23,760
ALLOGENE THERAPEUTICS INC10,479,7910-10,479,79112,3660—-12,366
MERUS N V395,7380-395,73820,9700—-20,970
VERONA PHARMA PLC4,129,6180-4,129,618387,4410—-387,441
Page 1 of 1
Darwin Global Management, Ltd. — 13F Holdings — Q3 2025 | TickerTrail